1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity

Eur J Med Chem. 2019 Aug 15:176:310-325. doi: 10.1016/j.ejmech.2019.05.024. Epub 2019 May 11.

Abstract

A series of compounds generated by ring expansion/opening and molecular elongation/simplification of the 1,3-dioxolane scaffold were prepared and tested for binding affinity at 5-HT1AR and α1 adrenoceptors. The compounds with greater affinity were selected for further functional studies. N-((2,2-diphenyl-1,3-dioxan-5-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-ammonium hydrogen oxalate (12) emerged as highly potent full agonist at the 5-HT1AR (pKi 5-HT1A = 8.8; pD2 = 9.22, %Emax = 92). The pharmacokinetic data in rats showed that the orally administered 12 has a high biodistribution in the brain compartment. Thus, 12 was further investigated in-vivo, showing an anxiolytic and antidepressant effect. Moreover, in the formalin test, 12 was able to decrease the late response to the noxious stimulus, indicating a potential use in the treatment of chronic pain.

Keywords: 1,3-Dioxane; 5-HT1A receptor agonist; Anti-depressant; Antinociceptive activity; Anxiolytic.

MeSH terms

  • Analgesics / chemical synthesis
  • Analgesics / pharmacokinetics
  • Analgesics / therapeutic use*
  • Analgesics / toxicity
  • Animals
  • Anti-Anxiety Agents / chemical synthesis
  • Anti-Anxiety Agents / pharmacokinetics
  • Anti-Anxiety Agents / therapeutic use*
  • Anti-Anxiety Agents / toxicity
  • Antidepressive Agents / chemical synthesis
  • Antidepressive Agents / pharmacokinetics
  • Antidepressive Agents / therapeutic use*
  • Antidepressive Agents / toxicity
  • Brain / metabolism
  • Dioxanes / chemical synthesis
  • Dioxanes / pharmacokinetics
  • Dioxanes / therapeutic use*
  • Dioxanes / toxicity
  • Male
  • Neuroprotective Agents / chemical synthesis
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / therapeutic use*
  • Neuroprotective Agents / toxicity
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Receptors, Adrenergic, alpha-1 / metabolism
  • Serotonin 5-HT1 Receptor Agonists / chemical synthesis
  • Serotonin 5-HT1 Receptor Agonists / pharmacokinetics
  • Serotonin 5-HT1 Receptor Agonists / therapeutic use*
  • Serotonin 5-HT1 Receptor Agonists / toxicity
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Analgesics
  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Dioxanes
  • Neuroprotective Agents
  • Receptors, Adrenergic, alpha-1
  • Serotonin 5-HT1 Receptor Agonists
  • Receptor, Serotonin, 5-HT1A